Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma (Q27853163)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma |
scientific article |
Statements
1 reference
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma (English)
1 reference
Cristina Zahonero
Pilar Aguilera
Carmen Ramírez-Castillejo
Marta Pajares
Maria Victoria Bolós
Aurelio Hernández-Laín
Juan Manuel Sepúlveda
July 2015
0 references
Identifiers
2 references
2 references